Clinical Trial Update: Efficacy and Safety of Changkang Granule in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of Changkang Granule for diarrhea-predominant irritable bowel syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome with Diarrhea

Drugs mentioned

• Changkang Granule

Snippet

Sponsor: Tasly Pharmaceutical Group Co., Ltd | Conditions: Irritable Bowel Syndrome with Diarrhea | Phase 2 | Status: COMPLETED